Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Active bmn 111: daily subcutaneous injection of 15 ug/kg of bmn 111	-	-	-	-	[1] 276 💬
2	Bgj398 (also known as bbp-831)	-	-	-	-	[1] 276 💬
3	Bmn 111	-	-	-	-	[1] 276 💬
4	C-type natriuretic peptide conjugated to multi-arm polyethylene glycol carrier through a cleavable linker	Polyethylene glycol	[1] D03370 💬	-	-	[1] 276 💬
5	Infigratinib	Infigratinib	[1] D11589 💬	[3] FGFR1, FGFR2, FGFR3 💬	[21] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis	[1] 276 💬
6	Infigratinib 0.016 mg/kg	Infigratinib	[1] D11589 💬	[3] FGFR1, FGFR2, FGFR3 💬	[21] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis	[1] 276 💬
7	Infigratinib 0.032 mg/kg	Infigratinib	[1] D11589 💬	[3] FGFR1, FGFR2, FGFR3 💬	[21] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis	[1] 276 💬
8	Infigratinib 0.064 mg/kg	Infigratinib	[1] D11589 💬	[3] FGFR1, FGFR2, FGFR3 💬	[21] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis	[1] 276 💬
9	Infigratinib 0.128 mg/kg	Infigratinib	[1] D11589 💬	[3] FGFR1, FGFR2, FGFR3 💬	[21] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis	[1] 276 💬
10	Infigratinib phosphate	Infigratinib	[1] D11589 💬	[3] FGFR1, FGFR2, FGFR3 💬	[21] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis	[1] 276 💬
11	Modified recombinant human c-type	-	-	-	-	[1] 276 💬
12	Modified recombinant human c-type natriuretic peptide	-	-	-	-	[1] 276 💬
13	Modified rhcnp	-	-	-	-	[1] 276 💬
14	Natriuretic peptide	-	-	-	-	[1] 276 💬
15	Normal saline	-	-	-	-	[16]  6 , 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 276, 296, 299 💬
16	Pf-07256472	-	-	-	-	[1] 276 💬
17	Phosphate	Phosphate ion	-	-	-	[30]  2 ,  3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬
18	Placebo	-	-	-	-	[26]  3 ,  5 ,  6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬
19	Polyethylene glycol	Polyethylene glycol	[1] D03370 💬	-	-	[5] 96, 97, 235, 276, 299 💬
20	Recifercept	-	-	-	-	[1] 276 💬
21	Recifercept (proposed inn)	-	-	-	-	[1] 276 💬
22	Somatropin	Somatotropin	[1] D02691 💬	[1] GHR 💬	[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway	[16]  2 ,  3 , 19, 46, 74, 75, 78, 96, 113, 187, 193, 195, 265, 274, 276, 299 💬
23	Ta-46	-	-	-	-	[1] 276 💬
24	Tbd	-	-	-	-	[4] 19, 86, 276, 299 💬
25	Transcon cnp	-	-	-	-	[1] 276 💬
26	Transcon cnp 3.9 mg cnp-38/vial	-	-	-	-	[1] 276 💬
27	Vorsoritide	-	-	-	-	[1] 276 💬
28	Vosoritide	Vosoritide	[1] D11190 💬	-	-	[1] 276 💬

Back to top